Park Ha Biological Technology (BYAH) Payables (2023 - 2026)

Park Ha Biological Technology has reported Payables for 4 years, with the latest figure at $72674.0 in Q2 2026.

• On a quarterly basis, Payables fell 9.0% year-over-year to $72674.0 in Q2 2026; TTM through Apr 2026 was $72674.0, a 9.0% decrease from a year earlier, with the FY2025 full-year figure at $87928.0, up 14.47% from the prior year.
• Payables was $72674.0 for Q2 2026 at Park Ha Biological Technology, down from $87928.0 in the prior quarter.
• The five-year high for Payables was $206647.0 in Q4 2023, with the low at $72674.0 in Q2 2026.
• Average Payables over 4 years is $104785.2, with a median of $79863.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Payables slumped 62.83% in 2024, then climbed 14.47% in 2025.
• Over 4 years, Payables stood at $206647.0 in 2023, then tumbled by 62.83% to $76814.0 in 2024, then climbed by 14.47% to $87928.0 in 2025, then declined by 17.35% to $72674.0 in 2026.
• The last three Payables figures came in at $72674.0 (Q2 2026), $87928.0 (Q4 2025), and $79863.0 (Q2 2025), per Business Quant data.